ORLANDO HEALTH
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $30.9M
- Transactions
- 5,147
- Companies
- 40
- Average per transaction
- $6,011
Who reported the payments
| Novartis | $3,756,420 |
| Regeneron | $2,772,014 |
| Boston Scientific | $2,700,541 |
| Merck | $2,611,922 |
| Modernatx, Inc. | $1,287,476 |
| Medtronic | $1,164,620 |
| QOL Medical, LLC | $1,112,238 |
| Amgen | $708,411 |
| AbbVie | $708,225 |
| Janssen Research & Development, LLC | $691,303 |
| Olympus Corporation Of The Americas | $688,446 |
| Genentech, Inc. | $656,500 |
| Iovance Biotherapeutics, Inc. | $626,937 |
| Pfizer | $621,527 |
| Takeda Pharmaceuticals U.S.A., Inc. | $604,996 |
| Boehringer Ingelheim | $558,308 |
| Johnson & Johnson | $525,519 |
| Celularity Inc. | $445,300 |
| Atricure, Inc. | $427,461 |
| Gilead | $416,815 |
| E.r. Squibb & Sons, L.L.C. | $402,879 |
| Sanofi | $389,290 |
| Biogen | $378,078 |
| Macrogenics, Inc. | $328,569 |
| Immunocore Limited | $290,193 |
| Abbott | $272,367 |
| AstraZeneca | $236,303 |
| Fujifilm Healthcare Americas Corporation | $229,814 |
| Genmab A/s | $208,870 |
| Biotronik Inc. | $197,159 |
| Medline Industries LP | $192,045 |
| Clovis Oncology, Inc. | $169,638 |
| Medical Device Business Services, Inc. | $163,436 |
| Microvention, Inc. | $163,293 |
| Astrazeneca UK Limited | $153,996 |
| Viewray Technologies Inc | $151,336 |
| Gynesonics, Inc. | $147,599 |
| Olympus America Inc. | $145,912 |
| Smith+Nephew | $141,387 |
| Angiodynamics, Inc. | $134,814 |